Literature DB >> 28049397

Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players.

Kazimierz Gasiorowski1, Barbara Brokos1, Jerzy Leszek2, Vadim V Tarasov3, Ghulam Md Ashraf4, Gjumrakch Aliev5,6.   

Abstract

Glucose homeostasis is crucial for neuronal survival, synaptic plasticity, and is indispensable for learning and memory. Reduced sensitivity of cells to insulin and impaired insulin signaling in brain neurons participate in the pathogenesis of Alzheimer disease (AD). The tumor suppressor protein p53 coordinates with multiple cellular pathways in response to DNA damage and cellular stresses. However, prolonged stress conditions unveil deleterious effects of p53-evoked insulin resistance in neurons; enhancement of transcription of pro-oxidant factors, accumulation of toxic metabolites (e.g. ceramide and products of advanced glycation) and ROS-modified cellular components, together with the activation of proapoptotic genes, could finally induce a suicide death program of autophagy/apoptosis in neurons. Recent studies reveal the impact of p53 on expression and processing of several microRNAs (miRs) under DNA damage-inducing conditions. Additionally, the role of miRs in promotion of insulin resistance and type 2 diabetes mellitus has been well documented. Detailed recognition of the role of p53/miRs crosstalk in driving insulin resistance in AD brains could improve the disease diagnostics and aid future therapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer disease; Insulin resistance; ROS; microRNAs; p53 protein

Mesh:

Substances:

Year:  2017        PMID: 28049397     DOI: 10.2174/1568026617666170103161233

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  6 in total

1.  miR-23b-3p rescues cognition in Alzheimer's disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways.

Authors:  Hailun Jiang; Jianghong Liu; Shuilong Guo; Li Zeng; Zhongdi Cai; Junxia Zhang; Linlin Wang; Zhuorong Li; Rui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2022-04-18       Impact factor: 10.183

2.  The Relationship Between Menopause and Metabolic Syndrome: Experimental and Bioinformatics Analysis.

Authors:  Abir Jaballah; Ismael Soltani; Wael Bahia; Azza Dandana; Yosra Hasni; Abdelhedi Miled; Salima Ferchichi
Journal:  Biochem Genet       Date:  2021-05-10       Impact factor: 1.890

3.  Microarray Profile of Long Noncoding RNA and Messenger RNA Expression in a Model of Alzheimer's Disease.

Authors:  Linlin Wang; Li Zeng; Hailun Jiang; Zhuorong Li; Rui Liu
Journal:  Life (Basel)       Date:  2020-05-14

Review 4.  EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease.

Authors:  Vladimir Khavinson; Natalia Linkova; Ekaterina Kozhevnikova; Svetlana Trofimova
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

5.  Implications of miR-148a-3p/p35/PTEN signaling in tau hyperphosphorylation and autoregulatory feedforward of Akt/CREB in Alzheimer's disease.

Authors:  Li Zeng; Hailun Jiang; Ghulam Md Ashraf; Jianghong Liu; Linlin Wang; Kaiyue Zhao; Mimin Liu; Zhuorong Li; Rui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-29       Impact factor: 8.886

6.  Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link.

Authors:  Anna Brzecka; Natalia Madetko; Vladimir N Nikolenko; Ghulam M Ashraf; Maria Ejma; Jerzy Leszek; Cyryl Daroszewski; Karolina Sarul; Liudmila M Mikhaleva; Siva G Somasundaram; Cecil E Kirkland; Sergey O Bachurin; Gjumrakch Aliev
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.